The meeting spans a two-and-a-half-day program, consisting of invited lectures, abstract-driven scientific presentations, clinical case presentations, and poster sessions. The workshop will address important topics such as mechanisms and clinical implications of drug resistance, the epidemiology of drug resistance, resistance to new drugs, resistance technology, and managing HIV-HCV co-infection.
